[reaction: see text] In an effort to expand the scope of natural product in vitro glycorandomization (IVG), the substrate specificity of NovM was investigated. A test of four aglycon analogues and over 40 nucleotide sugars revealed NovM has a surprisingly stringent substrate specificity and provided only three new "unnatural" natural products. On the basis of the determined substrate specificity, an alternative to the sugar nucleotide biosynthetic dogma and a cautionary note for the general applicability of IVG are introduced.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ol0341086 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!